Similarly, altered bile acid metabolism mediated by gut microbiota-derived EVs disrupts farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 signaling (TGR5), contributing to hepatic steatosis and fibrosis [100]. This evidence concerns the gene NR1H4 and fatty liver disease.